CBOE CBOE Week ended 24 Jul 2026

Weekly Investor Report

Cboe Global Markets Inc · Financial Services · Financial Data & Stock Exchanges

Open interactive chart View report data Download investor PDF
Latest close 285.1 USD
4.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 40.4% of its 52-week range. The latest completed week returned 4.3%, after a 17.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 34/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 1d.

Setup score 48 out of 100
Latest Close 285.1 USD 24 Jul 2026
1W Return 4.3% latest completed week
4W Return 17.7% short-term follow-through
12W Return -12.6% quarterly tape
Trend Breadth 88.5% 46 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 61.60% based on similar historical setup states.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.3% Latest completed week; four-week move 17.7%. Indicator stack 49/28 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 61.60% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 34/100 conviction; expected move 6.2%. News sentiment 54/100 44 relevant articles in the latest sentiment read. Event risk 1d Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 40.4% of its 52-week range. The latest completed week returned 4.3%, after a 17.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4812-week average 0.80

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.7% over four weeks, -12.6% over 12 weeks, and 16.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.3%
4W17.7%
12W-12.6%
26W3.6%
52W16.8%
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.93Latest activity-pressure read.
Pressure change-71.2%Four-week change in activity pressure.
Leadership-2.02Latest relative-leadership reading.
RS change87.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value18/100Relative valuation strength. Underlying universe rank 83; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum34/100Medium-term price momentum. Underlying universe rank 67; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
24.2x
Price divided by trailing earnings.
Price / sales
6.2x
Market value relative to trailing revenue.
EV / EBITDA
15.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
52.2%
Gross profit retained from each unit of revenue.
Operating margin
37.2%
Operating profit retained from revenue.
Free-cash-flow margin
23.5%
Free cash flow generated from revenue.
Return on invested capital
26.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.6%
Latest one-year revenue growth.
EPS growth
53.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-4.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.5%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
0.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

CBOE shows mixed options pressure with a 34/100 conviction score, put-call volume ratio of 0.92, expected move of 6.2%, and Sharemaestro trend signal inactive.

Conviction34/100
Expected move6.2%
Put/call volume0.92
Pressure9
Speculation41
Volatility74
Trend agreement55
Open options detail
Insider activity12 / 2

12 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 44 relevant articles.

15 positive · 23 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings1dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
Options expected move6.2%Nearest-chain priced movement where available.
52-week drawdown-23.0%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+7.7%Week of 10 Jul.
Worst week-15.5%Week of 19 Jun.
Latest week+4.3%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains8
Flat weeks0
Modest losses5
Sharp losses4
Recent vol7.7%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis40/100

Latest 12-week confirmation: trend 6/12, activity pressure 6/12, relative leadership 5/12.

Activity pressure 0.48; 8 reversal markers Next-Week ExpectancyPositive 61.60%

Next-week expectancy is positive with a 61.60% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors44/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

CBOE shows mixed options pressure with a 34/100 conviction score, put-call volume ratio of 0.92, expected move of 6.2%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 6.2% Sentiment54/100

Weighted news tone is neutral across 44 relevant articles.

Cboe Global Markets Enters Third Amended And Restated Credit Agreement On July 24, 2026 - SEC Filing Insiders12 / 2

12 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings1d

Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026285.1 USD4.3%288.4 USD215.9 USD-0.93-2.024.5MOff
17 Jul 2026273.4 USD2.0%287.4 USD215.0 USD-0.95-6.586.0MOff
10 Jul 2026268.1 USD7.7%286.5 USD214.1 USD-0.93-9.886.3MOff
3 Jul 2026249.0 USD2.8%286.0 USD213.3 USD-0.80-15.246.7MOff
26 Jun 2026242.2 USD-2.8%286.1 USD212.5 USD-0.54-15.919.6MOff
19 Jun 2026249.1 USD-15.5%286.6 USD211.8 USD-0.07-15.7411.6MOff
12 Jun 2026294.9 USD4.6%286.6 USD211.0 USD0.570.467.2MOn
5 Jun 2026281.9 USD-15.5%285.3 USD210.0 USD1.21-3.3413.5MOn
29 May 2026333.6 USD-6.5%284.4 USD209.1 USD1.7311.575.0MOn
22 May 2026356.6 USD-1.6%281.4 USD207.8 USD1.9021.314.1MOn
15 May 2026362.2 USD4.1%277.5 USD206.3 USD1.6224.795.3MOn
8 May 2026347.8 USD6.6%273.3 USD204.8 USD1.2720.775.1MOn
1 May 2026326.3 USD7.6%269.8 USD203.5 USD0.9216.314.6MOn
24 Apr 2026303.2 USD1.3%266.9 USD202.2 USD0.559.384.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.